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Nature of glomerular dysfunction in pre-eclampsia.
Background. Pre-eclampsia is characterized by hypertension,
proteinuria and edema. Simultaneous studies of kidney function
and structure have not been reported. We wished to explore the
degree and nature of glomerular dysfunction in pre-eclampsia.
Methods. Physiologic techniques were used to estimate glomer-
ular filtration rate (GFR), renal plasma flow and afferent oncotic
pressure immediately after delivery in consecutive patients with
pre-eclampsia (PET; N 5 13). Healthy mothers completing an
uncomplicated pregnancy served as functional controls (N 5 12).
A morphometric analysis of glomeruli obtained by biopsy and
mathematical modeling were used to estimate the glomerular
ultrafiltration coefficient (Kf). Glomeruli from healthy female
kidney transplant donors served as structural controls (N 5 8).
Results. The GFR in PET was depressed below the control
level, 91 6 23 versus 149 6 34 ml/min/1.73 m2, respectively (P ,
0.0001). In contrast, renal plasma flow and oncotic pressure were
similar in the two groups (P 5 NS). A reduction in the density and
size of endothelial fenestrae and subendothelial accumulation of
fibrinoid deposits lowered glomerular hydraulic permeability in
PET compared to controls, 1.81 versus 2.58 3 1029 m/sec/PA.
Mesangial cell interposition also curtailed effective filtration
surface area. Together, these changes lowered the computed
single nephron Kf in PET below control, 4.26 versus 6.78 nl/min z
mm Hg, respectively.
Conclusion. The proportionate (;40%) depression of Kf for
single nephrons and GFR suggests that hypofiltration in PET does
not have a hemodynamic basis, but is a consequence of structural
changes that lead to impairment of intrinsic glomerular ultrafil-
tration capacity.
Pre-eclamptic toxemia (PET) is characterized by gesta-
tional hypertension, a phenomenon that has been attrib-
uted to an excess of vasoconstrictor over vasodilator influ-
ences in the systemic circulation [1–5]. A parallel imbalance
in the renal circulation would be expected to lower the
glomerular perfusion rate. Another characteristic of PET is
abnormal glomerular morphology [6–8], which could lower
the intrinsic ultrafiltration capacity of glomerular capillar-
ies. Limited glomerular ultrafiltration capacity on its own,
or more particularly, in combination with glomerular un-
derperfusion, is predicted to result in depression of the
glomerular filtration rate (GFR). Yet, as judged by eleva-
tion of serum creatinine concentration to abnormal levels,
depression of GFR is a sufficiently infrequent finding that
it is not used as a criterion for the diagnosis of PET [9–11].
The absence of azotemia, usually defined in females as a
serum creatinine concentration .1.2 mg/dl, does not ex-
clude a substantial PET-mediated reduction in GFR, how-
ever. GFR during the second half of pregnancy, when PET
is likely to become manifest, is normally elevated above
non-gravid levels by ;50% [12–14]. A reciprocal decline in
the serum creatinine level is typically to only ;0.6 mg/dl, on
average [13, 15]. Further, the relationship between GFR
and serum creatinine concentration is hyperbolic, that is, a
given percent reduction from high levels of the former
would result in a proportionately smaller percent increase
in the latter [16]. Thus, for serum creatinine to exceed 1.2
mg/dl as a result of PET would require a .50% depression
of GFR from prevailing gravid levels.
A major goal of the present study was to confirm that
PET indeed lowers the GFR, albeit insufficiently in most
cases to result in overt azotemia. A second goal was to
elucidate possible mechanisms by which PET lowers the
GFR. To accomplish this, we used a combination of
physiologic and morphometric techniques and mathemati-
cal modelling to evaluate individual determinants of the
GFR in subjects with PET. Our findings form the basis of
this report.
METHODS
Patient populations
Our experimental group comprised 13 of 15 consecu-
tively consenting mothers diagnosed with PET because of
the development of gestational hypertension and protein-
uria during the second-half of pregnancy [11]. Gestational
hypertension was defined as systolic and diastolic pressures
1 See Editorial by Chapman, p. 1394.
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in excess of 140 and 90 mm Hg respectively, in subjects not
known to have pregestational hypertension. Proteinuria
was defined as 21 by dipstick. Each recruited subject was
asked, but not required, to undergo a renal biopsy during
the first 48 postpartum hours. Of the ten subjects who
consented to the performance of a biopsy, only eight had a
constellation of histopathological changes typical of pure
PET. One of the remaining subjects was found to have
acute postinfectious glomerulonephritis, with endocapillary
cell proliferation and subepithelial, electron dense, “hump-
like” deposits. The other was found to have idiopathic focal
and segmental glomerulosclerosis with chronic renal dam-
age. Changes of PET in endothelial cells and subendothe-
lial fibrinoid deposits were absent. These two latter patients
were excluded from further analysis. The likelihood that
each of the remaining 13 subjects indeed had PET was
enhanced by the subsequent demonstration six weeks post-
partum that both the gestational hypertension and the
proteinuria had resolved.
Two groups of subjects served as controls. Twelve
healthy women completing an uncomplicated pregnancy
served as gravid controls. They provided reference values
for the physiological determinations of interest during the
first 24 postpartum hours. The PET and gravid control
groups were similar in age, averaging 34 6 2 (mean 6 SD)
and 30 6 1 year, respectively (P 5 NS). The second control
group was comprised of 8 healthy, female kidney transplant
donors in their reproductive years. Each underwent a renal
biopsy at the time of transplantation to provide control
values for the morphometric analysis of glomerular struc-
ture in PET. All members of the two control groups denied
a history of renal disease, hypertension or diabetes mellitus.
At the time of evaluation, each was found to be normoten-
sive and normoglycemic, to have a normal serum creatinine
level, and to have a urinary protein excretion rate within
the normal range.
Physiological evaluation
Our observations were made in the early postpartum
period. Glomerular filtration dynamics were evaluated by a
clearance technique, beginning 4.5 6 0.9 and 4.3 6 1.1 hour
after delivery by cesarean section in the subjects of the PET
and gravid control groups, respectively. We opted to study
postcesarean patients because the routine use of a bladder
catheter under these conditions permitted accurate mea-
surement of the urine flow rate and avoided contamination
of the urine sample by lochia. All subjects of both groups
were receiving i.v. Pitocin (oxytocin) at the time of study.
A priming dose of inulin (50 mg/kg) and para-aminohip-
puric acid (PAH, 12 mg/kg) was administered. Thereafter,
inulin and PAH were given by continuous infusion to
maintain plasma levels constant at 20 and 1.5 mg/dl,
respectively. Sixty minutes after the priming infusion, arte-
rial blood pressure was determined by Dynamap, and blood
was sampled for examination of plasma oncotic pressure
(pA) and plasma albumin concentration. Four consecutive
30-minute urine samples were then carefully collected,
each bracketed by a blood sample drawn from a peripheral
vein. The GFR was expressed as the average value for the
four timed inulin clearances. The rate of renal plasma flow
(RPF) in the subjects with PET was determined by dividing
the corresponding clearance of PAH by an estimate of the
renal arteriovenous extraction ratio for PAH (EPAH). The
value for EPAH in each individual was estimated from a
quadratic regression model that uses the prevailing GFR
and post-glomerular oncotic pressure to derive EPAH in
subjects with glomerular disease [17]. According to this
model, EPAH averaged 0.76 and 0.90 in subjects with PET
and controls, respectively. The extent of albuminuria was
evaluated by determining the albumin-to-creatinine ratio in
the first of the timed urine collections.
The concentrations of inulin and PAH were determined
with an automated assay [16, 17]. Concentrations of albu-
min in serum and urine were determined by immunochemi-
cal methods and plasma oncotic pressure by membrane
osmometry as described previously [18]. The oncotic pres-
sure in systemic plasma was taken to be the same as that
entering the afferent glomerular arteriole (pA). Efferent
oncotic pressure (pE) was calculated as:
pE 5 pA/(1 2 FF) (Eq. 1)
where FF is filtration fraction (GFR/RPF). Assuming that
the axial rise in oncotic pressure along the glomerular
capillaries is linear, we then computed the mean intralumi-
nal glomerular oncotic pressure (pGC) as the arithmetic
mean of pA and pE [18].
Renal biopsy
Renal biopsy of the pre-eclamptic mothers was per-
formed within 48 hours following delivery. Two cores were
taken with a 16-gauge biopsy gun needle (Bard Monopty,
Covington, GA, USA) under ultrasonic guidance. The first
core and the central portion of the second core were
prepared for light and transmission electron microscopy
respectively, as described previously [19]. The two remain-
ing outer portions of the second core were prepared for
scanning electron microscopy (SEM), using a modification
of the method of Shirato et al [20]. Briefly, freshly biopsied
kidney tissue was immediately fixed in 4% glutaraldehyde
in PBS, pH 7.4, and stored at 4°C. Before post-fixation, the
samples were examined with a stereoscope. A cut was made
near or through glomeruli in the samples. The samples
were then washed in 0.1 M sodium cacodylate followed by
three complete cycles of: a two hour post-fixation with 1%
osmium tetroxide, a 20 minute wash with sodium cacody-
late buffer, two hours of incubation in 1% tannic acid, and
a 20-minute sodium cacodylate buffer wash. The samples
were then dehydrated in a series of alcohols, immersed in
hexamethylsilisane and allowed to dry thoroughly in a
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dessiccator. The samples were finally placed on aluminum
stubs, coated with gold, observed with a Philips 505 scan-
ning electron microscope, and rotated and tilted to allow
examination of glomerular endothelial surfaces en face.
The images were recorded on Polaroid film.
Morphometric evaluation
All glomeruli in a single 1 mm paraffin-embedded section
stained with periodic acid-Schiff reagent were analyzed at
the light microscopic level. On average, 21 (range 6 to 41)
glomeruli were examined in the biopsy material from
subjects with PET. The average number of glomeruli
among the control biopsies was 23 (range 9 to 62). A
dedicated computer system (Southern Micro Instruments,
Inc., Atlanta, GA, USA), consisting of a video camera,
screen, microscope and digitizing tablet, was used to per-
form measurements. The outline of each glomerular tuft in
the cross-section was traced onto the digitizing tablet at
900 3 and the tuft cross-sectional area (AG) computed
from a polygon that was fitted to its outline as described by
Weibel and Gomez [21]. Glomerular volume (VG) was then
calculated from AG as follows:
VG 5
b
d~AG!
3/2~ƒsƒi!23 (Eq. 2)
where b is a dimensionless “shape coefficient” (b 5 1.38 for
spheres), d is a “size distribution coefficient,” which is
introduced to account for variations in glomerular size [21]
and fs and fi are correction factors for the tissue shrinkage
associated with paraffin embedding and immersion fixation,
respectively. We used d 5 1.1 as in previous studies [19, 22],
which corresponds to a distribution of glomerular sizes with
a SD of ;25% of the mean size [21]. We have determined
that the value of the shrinkage factors in our embedding
procedure and during immersion fixation are fs 5 0.86 and
fi 5 0.85, respectively [22, 23].
Two or three Epon-embedded glomeruli centrally lo-
cated within the block were randomly chosen from each
biopsy and thin-sectioned (70 nm) for examination by
TEM. Montage micrographs of full glomerular profiles
(32820) were prepared for measurement by point and
intercept counting of “effective” filtering surface density
(Sv) of the peripheral glomerular capillary wall (GCW). In
the past we have defined Sv as the length density of the
peripheral GBM from mesangial junction to mesangial
junction [19, 22]. Among the changes that characterized
PET, however, were mesangial cell interposition and hy-
pertrophy of endothelial cell bodies (vide infra). The part of
the GBM that was apposed to these aforementioned struc-
tures was excluded on the grounds that transcellular filtra-
tion is negligible, and this component was designated
“ineffective” filtration surface density. For purposes of the
present study therefore, “effective” filtration surface den-
sity was defined as the remaining length density of periph-
eral GBM, that is, that which is apposed to the endothelial
cytoplasmic rim.
Six-eight sections of each randomized glomerular profile
were then photographed at 311,280 to evaluate the dimen-
sions of the filtration barrier. The frequency of filtration
slits was determined by counting the total number of
epithelial filtration slits and dividing it by the total length of
the peripheral glomerular basement membrane (GBM)
captured on the electron photomicrographs. The harmonic
mean thickness of the filtering GBM (dbm) and separately,
of the entire glomerular capillary wall (dgcw, that is, the
interval of the filtration pathway from fenestrae to slit
diaphragms) was then calculated using the orthogonal
intercept method of Jensen [24]. In controls dbm 5 dgcw. In
subjects with PET, however, dgcw . dbm, with the excess
reflecting subendothelial fibrinoid deposits that lay free
between the endothelial fenestrae and the lamina rara
interna of the GBM (vide infra). Finally, scanning electron
microscopy was used to characterize endothelial fenestral
dimensions. Polaroid photographs of endothelial surfaces
were digitized on a flat bed scanner by adjusting the (grey
scale) image threshold. Three random areas, each of 1 mm2,
were then defined to serve as reference areas. Micrographs
(320,000) taken normal to the plane of exposed endothe-
lium (“en face”) were used to determine fenestral density
by manual counting. Higher magnification (350,000) was
next used to calculate the size of all fenestrae in the
reference area, and the fraction of underlying and filtering
GBM occupied by fenestrae using the NIH Image program
(version 1.45).
Calculation of the glomerular ultrafiltration coefficient
Single nephron (SN) Kf was calculated from the product
of filtration surface area (S) and an estimate of the
hydraulic permeability of the walls of glomerular capillaries
(k) in the 2 to 3 glomeruli examined ultrastructurally. S was
first calculated from:
S 5 Sv 3 VG~fifs! (Eq. 3)
where Sv and VG are respectively the mean values for
“effective” peripheral capillary surface density and glomer-
ular volume in each biopsy core.
The hydraulic permeability of the capillary wall (k) was
estimated from the filtration slit frequency, basement mem-
brane thickness (dbm), glomerular capillary wall thickness
(dgcw), number of fenestrae per unit area of endothelial
surface (nf), and fenestral area/perimeter ratio using the
ultrastructural-hydrodynamic model of Drumond and
Deen [25]. In the model, the normal capillary wall is
represented as consisting of a large number of repeating
structural units, each of which is based on a single filtration
slit. The width of a structural unit (W) is calculated as:
W 5
2
p
3
1
FSF (Eq. 4)
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where FSF is the filtration slit frequency and 2/p is a
correction factor that accounts for the random angle of
sectioning. The overall hydraulic permeability is related to
the permeabilities of the individual layers by:
k 5 S 1ken 1 1kbm 1 1kepD
21
(Eq. 5)
where ken, kbm and kep are the hydraulic permeabilities of
the endothelium, basement membrane, and epithelium,
respectively.
The endothelial permeability is given by:
ken 5 efkf (Eq. 6)
where ef is the fraction of the capillary surface occupied by
fenestrae and kf is the permeability of a single fenestra. In
addition to changes in the number density of fenestrae, ef is
influenced by the size of an individual fenestra. The
characteristic linear dimension of a fenestra is proportional
to the area of the opening divided by its perimeter; the
area-perimeter ratio is denoted as L. Hydrodynamically,
the fenestrae may be viewed as orifices in a thin wall.
Dimensional analysis of the equations for flow through an
orifice at low Reynolds number indicates that the hydraulic
permeability of the orifice is given by cL/m, where c is a
dimensionless constant that depends on the orifice shape
and m is the viscosity of the fluid. Thus, for flow of water
through orifices of similar shape but differing size, the
hydraulic permeability is predicted to vary in proportion to
L.
The effective permeability of the basement membrane is
governed by a relationship of the form:
kbm 5
KD
mdbm
ƒ SWdbm,Nf,ef,esD (Eq. 7)
where kD is the Darcy permeability and dbm is the thickness
of the GBM, m is the viscosity of water, Nf is the number of
fenestrae per structural unit, es is the fraction of the
basement membrane area occupied by filtration slits, and
the function f is given by equation 23 of Drumond and
Deen [25]. The fractional slit area is given by es 5 Ws/W,
where Ws is the width of a filtration slit at the level of the
slit diaphragm. On the basis of the reduction in fenestral
number density (nf) in PET, the number of fenestrae per
repeating unit (Nf) was reduced from 3 (the control value)
to 2. The quantities KD and Ws were estimated using
literature data for rats as detailed previously [19, 22]. In
PET, however, only part of glomerular capillary wall thick-
ness is accounted for by GBM; the remainder is comprised
of subendothelial fibrinoid material (vida infra). Not only is
the Darcy permeability (KD) of the latter material not
known, but in the absence of knowledge of its precise
composition it is not yet possible to measure its KD in vitro.
We accordingly resorted to a limited sensitivity analysis and
examined the effects of variations of KD for this “non-
GBM” fraction on kbm. We solved equation (7) for PET by
assigning values of KD that are either negligible (that is,
fibrinoid imposes no resistance to water flow), or the same
as the in vitro estimate for GBM. In the former instance
only actual dbm was considered, whereas in the latter
instance the thickness of the entire filtration pathway (dgcw)
was substituted for dbm in equation (7).
Finally, the epithelial permeability was computed as:
kep 5 esks 5
Ws
W ks (Eq. 8)
where ks is the permeability of the slit diaphragm, as
estimated previously based on structural data for the rat
[25].
Statistical analysis
All results, except for the urinary albumin excretion rate,
are expressed as the mean 6 ISD. Student’s t-test was used
to test the significance of differences between the PET and
corresponding control groups.
RESULTS
Clinical features
The appearance of dipstick proteinuria and the required
level of hypertension (.140/.90 mm Hg), preceded deliv-
ery in the PET group by 5.7 6 5.8 and 4.4 6 4.9 days,
respectively. At the time of examination in the immediate
wake of delivery, the PET group differed from the healthy
gravid control group in three respects: (1) the period of
gestation was shorter, 34 6 5 versus 39 6 1 week (P ,
0.05); (2) infant birth weight was lower, 1.9 6 0.9 versus
3.7 6 3.0 Kg (P 5 0.0004), a difference that indicates
immaturity as well as prematurity in the former; and (3) all
subjects with PET were receiving treatment with MgSO4
and in two instances, with nifedipine, whereas no group 2
subject received MgSO4 or antihypertensive drugs. Despite
the latter therapy, mean arterial pressure was significantly
higher in PET than in the gravid controls, averaging 104 6
12 versus 81 6 6 mm Hg, respectively (P , 0.001, Table 1).
The urinary albumin/creatinine ratio was also significantly
greater in PET than in gravid controls (Table 1).
Table 1. Clinical features
Controls PET
Age years 30 6 1 34 6 2
Gestational age weeks 39 6 1 34 6 5a
Infant birth weight kg 3.7 6 3.0 1.9 6 0.9a
Mean arterial pressure mm Hg 81 6 6 104 6 12a
Serum creatinine mg/dl 0.60 6 0.10 0.83 6 0.22a
Urine albumin:creatinine mg/g 32 6 10 2810 6 89a
Data are mean 6 SD.
a P , 0.05, PET vs. controls
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Filtration dynamics
Similar to the observations of others during late preg-
nancy, the GFR in our gravid control subjects was elevated
above normal non-gravid levels by ;50%, averaging 149 6
34 ml/min/1.73 m2 [12, 14, 15, 26]. We have thus demon-
strated that pregnancy-associated hyperfiltration persists
into the first postpartum day. When compared to this high
value, the corresponding GFR in PET was significantly
depressed, averaging only 91 6 25 ml/min/1.73 m2 (P ,
0.001, Table 2). Of note, the corresponding levels of serum
creatinine in the control and PET groups were 0.60 6 0.10
and 0.83 6 0.22 mg/dl, respectively (P , 0.001, Table 1).
Because of the hyperbolic relationship between this quan-
tity and GFR, the highest serum creatinine in the PET
group was only 1.2 mg/dl, despite simultaneous depression
of corresponding GFR to 44 ml/min/1.73 m2.
Unlike the GFR, renal plasma flow in gravid controls was
not elevated above normal non-gravid levels, averaging
624 6 108 ml/min/1.73 m2. The corresponding renal plasma
flow in the PET group was similar averaging 648 6 257
ml/min/1.73 m2 (P 5 NS, Table 2). The selective decline in
PET of GFR resulted in marked depression of the filtration
fraction, 16 6 5 versus 24 6 5% in controls (P , 0.001,
Table 1). This latter finding indicates that determinants of
GFR other than renal plasma flow must have been altered
to explain the observed level of hypofiltration in PET.
A consistently reported finding of hypoalbuminemia in
pregnancy has been attributed to a combination of hyper-
volemia (hemodilution) and altered protein metabolism
[27–31]. We found serum albumin concentration to be
markedly depressed in both groups, slightly more so in PET
than gravid controls, 1.87 6 0.20 versus 1.95 6 0.22 g/dl,
respectively (P 5 NS). The corresponding oncotic pressure
of preglomerular plasma (pA) varied in parallel, 17.0 6 2.7
versus 17.6 6 1.3 mm Hg (Table 2). Reflecting the lower
filtration fraction in PET, we calculate that the disparity in
oncotic pressure along the glomerular capillaries grew
larger, such that pGC averaged 18.6 6 3.2 versus 20.4 6 1.7
mm Hg in the gravid controls. The difference failed nar-
rowly to reach statistical significance (P 5 0.07). However,
since pGC is the force opposing the formation of filtrate, the
trend towards depression of this quantity should have
enhanced ultrafiltration pressure and hence, increased
GFR [32]. It follows that depression of either the glomer-
ular transcapillary hydraulic pressure difference and/or the
glomerular ultrafiltration coefficient (Kf) must be invoked
to explain the hypofiltration observed in PET.
Glomerular structure and morphometry
Examination by light microscopy revealed prominence of
endocapillary (mesangial and endothelial) cells. There was
conspicuous endothelial cellularity in most cases, evidenced
by up to three endothelial cell nuclei in some capillary
lumens. Definite mesangial hypercellulartiy was difficult to
discern. There was also a prominent infiltration of macro-
phages and a lesser number of lymphocytes and polymor-
phonuclear leukocytes within capillary lumens in four of
the cases. The hypertrophy of endothelial cells alone, or in
combination with leukocyte infiltrates, resulted in obvious
loss of capillary patency in all seven cases by light micros-
copy. Foamy macrophages were appreciated in two of the
cases. There also was variable thickening of glomerular
capillary walls. This appeared to be related to mesangial
interposition in all cases, and prominent subendothelial
hyaline deposits in one case. An additional finding was the
presence of early focal segmental glomerular sclerosis in
four out of seven of the individuals, affecting 19 6 11% of
glomeruli, on average. Examination by transmission elec-
tron microscopy confirmed the finding of endothelial cell
hyperplasia, as well as that of exudation of foamy macro-
phages, lymphocytes and polymorphonuclear leukocytes
within the capillary lumina and mesangium. In addition,
capillary wall abnormalities that are illustrated and sche-
matized in Figures 1 and 2, respectively, were apparent.
These included: (1) hypertrophied endothelial cells; (2)
swollen segments of endothelial cytoplasmic rim in which
fenestrae were not discernible; (3) subendothelial fibrinoid
and granular deposits; and (4) interposition of mesangial
cells.
Glomerular volume in PET was significantly larger than
in controls, 5.23 6 2.16 versus 3.29 6 1.19 mm3 3 106,
respectively (P , 0.05, Table 3). As stated previously, we
defined “effective” filtration surface as that part of the
peripheral GBM that was apposed to the fenestrated
endothelial cytoplasmic rim. The remaining part of the
peripheral GBM that was apposed to endothelial cell
bodies or interposed mesangial cells (numbers 1 and 4,
respectively, Fig. 2) was excluded on the grounds that
transcellular filtration is negligible. This latter component,
which comprised the “ineffective” filtration surface density,
was increased by a factor of 3 in PET versus controls
(0.024 6 0.001 vs. 0.008 6 0.001, mm2/mm3, P 5 0.001),
mostly as a consequence of interposed mesangial cells. As
a result, effective Sv was reduced in PET versus controls,
averaging 0.055 6 0.002 versus 0.100 6 0.013, mm2/mm3
(P , 0.001, Table 3). However, a trend to larger glomerular
volume in PET offset the reduction in Sv. As a result, actual
filtration surface area calculated from equation (3) in PET
was reduced below control by only 10% (P 5 NS, Table 4).
Table 2. Renal hemodynamics
Controls PET
Glomerular filtration rate ml/min/1.73 m2 149 6 34 91 6 25a
Renal plasma flow ml/min/1.73 m2 624 6 108 648 6 257
Filtration fraction % 24 6 5 16 6 5a
Afferent oncotic pressure (pA) mm Hg 17.6 6 1.3 17.0 6 2.7
Glomerular oncotic pressure (pGC) mm Hg 20.4 6 1.7 18.6 6 3.2
Data are mean 6 SD.
a P , 0.05, PET vs. controls
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Fig. 1. Transmission electron microscopy (31800) of a representative glomerular capillary enumerating pathologic changes associated with pre-
eclampsia.
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There was only occasional and patchy broadening of
epithelial foot processes in PET, with the result that the
filtration slit frequency was not significantly reduced below
control (FSF; Table 3). There was also no significant
thickening of the peripheral GBM in PET (dbm; Table 3).
There were, however, extensive dense deposits of fibrinoid
material in a subendothelial location (#3, Fig. 2). These
resulted in a proportionately greater thickening of the
entire filtration pathway (dgcw) (from fenestral interface to
slit diaphragm) in PET versus control, 589 6 136 versus
391 6 77 nm, respectively (P , 0.001; Table 3). Ten
glomeruli from five subjects with PET were captured en
face on their endothelial aspect in scanning electron pho-
tomicrographs. Similar photographs of seven glomeruli
from the last three kidney donors in this series provided
control values (Fig. 3). Judged by a number density of 33 6
15 versus 49 6 21 per mm2, fenestral density was lower in
PET than controls (Table 3). A smaller area-to-perimeter
ratio attested to a reduction in endothelial fenestral size in
PET versus control (Table 3). Together, reduced fenestral
density and size in PET resulted in a smaller fraction of
GBM occupied by fenestrae (ef) than in controls. This
phenomenon is clearly visible by inspection of the digitized
tracings that are taken from a control (left) and a repre-
sentative subject with PET (right, Fig. 3). Whereas ef
closely approximated 0.16 in all control glomeruli, it was
uniformly reduced in glomeruli from the subjects with PET,
averaging only 0.046, and varying between 0.014 and 0.087
(Table 3; P , 0.001).
Computed filtration capacity
The single nephron ultrafiltration coefficient (SNKf) and
its determinants are summarized in Table 4. SNKf has been
calculated from the mean group, rather than individual
values of its structural determinants. This is because only
subsets of each group had fenestral density and dimensions
assessed by scanning EM (vide supra). As shown, endothe-
lial permeability (ken) was substantially reduced and epi-
thelial permeability (kep) slightly lower in PET than in
controls. Basement membrane permeability in PET was
depressed below control by 22 or 33%, depending on
whether fibrinoid is freely permeable to water (condition
A) or has a KD similar to glomerular basement membrane
(Condition B; Table 4). From equation (5), we calculate
that overall k in PET was reduced below control not less
than 23% (Condition A) or more likely by 30% (Condition
B), which is respectively 1.81 versus 2.5 3 1021 m/s/PA
(Table 4). In Condition B, approximately 50% of the
reduction was attributable to the fenestral changes, 30% to
Fig. 2. Schematic depiction of ultrastructural changes in pre-eclampsia. Key: 1, endothelial cell body; 2, swollen, non-fenestrated endothelial
cytoplasm; 3, subendothelial fibrinoid deposition; 4, mesangial cell interposition.
Table 3. Morphologic data
Controls PET
Glomerular volume (Vg) mm3 3 106 3.29 6 1.19 5.23 6 2.16b
Effective surface density (Sv)
mm2/mm3
0.100 6 0.013 0.055 6 0.017b
Filtration slit frequency
(FSF) per mm GBM
1264 6 181 1133 6 163
Thickness GBM (dbm) nm 391 6 77 403 6 109
Thickness GC wall (dgcw) nm 391 6 77 589 6 136
b
Fenestral density (nf) mm
2 49 6 21 33 6 15
Fenestral area-to-perimeter (A/P) 0.0096 6 0.0051 0.0045 6 0.0011b
Fraction GBM occupied by
fenestrae (ef)
0.1370 6 0.0176 0.046 6 0.028b
For SEM, N 5 7 gloms in 3 controls and N 5 10 gloms in 5 PET subjects.
b P , 0.05 vs. controls
Table 4. Glomerular ultrafiltration capacity
Controls
Pre-eclampsiaa
Condition
A
Condition
B
ken m/s/PA 1.37 3 10
27 2.16 3 1028 2.16 3 1028
kbm m/s/PA 4.62 3 10
29 3.62 3 1029 3.08 3 1029
kep m/s/PA 6.12 3 10
29 5.48 3 1029 5.48 3 1029
Overall k m/s/PA 2.58 3 1029 1.98 3 1029 1.81 3 1029
S mm2 3.28 3 105 2.95 3 105 2.95 3 105
SNKf nl/min z mm Hg 6.78 4.67 4.26
Abbreviations are: ken, kbm and kep, hydraulic permeabilities of endo-
thelium, basement membrane and epithelium, respectively; overall k is
overall hydraulic permeability of the capillary wall; S, effective filtration
surface area; SNKf, single nephron ultrafiltration coefficient.
a Condition A assumes that subendothelial fibrinoid is freely permeable
to water, whereas condition B assumes that the Darcy permeability of
fibrinoid is the same as that of GBM
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the thickening of the GBM and glomerular capillary wall,
and 20% to the reduction in filtration slit frequency. In
contrast, effective filtration surface area (S) was only
slightly reduced versus controls in PET (Table 4). This
reflects the fact that in PET, there were offsetting effects on
this quantity of reduced surface density and enhanced
glomerular volume (Table 3). From the product of S and k
we compute that SNKf in controls averaged 6.78 nl/(min z
mm Hg). The corresponding value in PET was substantially
lower at 4.26 to 4.67 nl/(min z mm Hg). Provided that
condition B applies, we note that the reduction in estimated
SNKf in PET is by 37% (Table 4), a change that is
remarkably similar to the corresponding reduction of 39%
in observed GFR in this disorder (Table 2).
DISCUSSION
Not one of the 13 consecutive patients suffering from
PET in the present study manifested azotemia. This is not
surprising considering that their GFR of 91 6 25 was only
slightly lower than the non-gravid value for healthy women,
which in our laboratory is 106 6 15 ml/min/1.73 m2. When
pregnancy-related hyperfiltration is taken into account,
however, it becomes evident that the GFR in our subjects
with PET was reduced fully 40% below the appropriate
control level (Table 2). Our morphometric analysis of
glomeruli suggests that an important, and perhaps predom-
inant reason for the hypofiltration in PET is impaired
hydraulic permeability of glomerular capillary walls, owing
mainly to reductions in fenestral density and size, and to
the accumulation beneath the endothelial monolayer of
fibrinoid deposits.
Although the histopathological alterations of glomeruli
in PET have been recognized for more than half a century
[1], recent investigators of this disorder have largely ig-
nored the possibility that glomerular capillary wall dysfunc-
tion could be responsible for its manifestations. Based
largely on in vitro study of the fetoplacental circulation,
authors of current reviews have implied that the glomerular
injury of PET is hemodynamic in nature. An increase in
renovascular resistance owing to an imbalance favoring
vasoconstrictor over vasodilator influences has been held
responsible [1–3, 5]. A recent body of evidence has pointed
to a central pathogenetic role for diminished activity of the
L-arginine-nitric oxide pathway [2, 5, 33, 34]. Indeed,
chronic administration of a nitric oxide synthase inhibitor
during the third trimester of pregnancy has gained currency
as an experimental model of PET in the rat. It results in
functional changes that resemble PET, including hyperten-
sion, proteinuria, depression of renal plasma flow and
GFR, retardation of fetal growth and increased fetal mor-
tality [33, 35, 36]. Whether or not these functional abnor-
malities are accompanied by typical abnormalities of glo-
merular morphology, however, has not been reported to
date.
In keeping with enhanced vasoconstrictor or diminished
vasodilator influences, renovascular resistance was numer-
ically higher in our PET than in our control group, albeit
not significantly so (120 6 46 vs. 92 6 18 mm Hg z min z
liter21, respectively). This trend did not result in a lower
glomerular perfusion rate (RPF; Table 2), but could have
depressed GFR by lowering glomerular perfusion pressure,
and hence the glomerular transcapillary hydraulic pressure
difference (DP). It seems doubtful that DP depression
could have made a major contribution to the observed
hypofiltration in PET, however. One reason for doubt is
that mean arterial pressure in PET exceeded the control
value by 23 mm Hg (Table 1). Given the insignificant trend
to higher renovascular resistance in PET than controls, it is
difficult to envisage a selective increase in preglomerular
segmental resistance of sufficient magnitude to prevent
some fraction of the excess in arterial pressure from being
transmitted into glomerular capillaries. These findings sug-
gest that efforts to directly alter renal plasma flow, such as
by infusion of fluids or plasma expanders or by use of
vasodilators, may not be beneficial in this disease process.
By making the conservative assumption that DP in PET is
the same as in controls, and assuming further that the value
for DP in each group approximates 40 mm Hg [22, 25], we
have used the measured values for GFR, renal plasma flow,
and pA to compute group values for two-kidney Kf from the
ultrafiltration model of Deen et al [32]. The two-kidney Kf
so calculated averaged only 4.8 6 2.0 in PET versus 8.6 6
Fig. 3. Scanning electron microscopy and digitized tracings of fenestrae in control (1A and 1B) and subjects with pre-eclampsia (2A and 2B).
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2.8 ml/(min z mm Hg) in controls, respectively (P , 0.001).
The 44% depression of the hypothetical two-kidney Kf in
PET, as calculated from physiological determinations, is
reassuringly similar to the corresponding 37% depression
of single nephron Kf in PET, as calculated by a morpho-
metric approach (Table 4). The accord between the two
independent approaches for estimating Kf suggests to us
that Kf depression is indeed the predominant cause of
hypofiltration in PET, and that it is unnecessary to invoke
a substantial role for simultaneous depression of DP in this
disorder.
We wish to point out that the morphometric approach
used to calculate single nephron Kf in the present study has
limitations. For example, we are forced to assume glomer-
ular shrinkage factors owing to immersion fixation and
paraffin embedding, so as to calculate glomerular volume.
To the extent that shrinkage may vary according to the
experimental conditions, the precision with which we have
calculated glomerular volume, and hence S, is likely to be
limited. Similarly, our computation of k depends on several
assumptions that are difficult to validate. Examples include
our assumption that the dimensions of apertures in the slit
diaphragm and the Darcy permeability of the GBM are the
same as in the rat. Even more problematic is that ;30% of
glomerular capillary wall thickness in PET is comprised of
subendothelial fibrinoid material, for which no in vitro
estimate of the Darcy permeability is available. In an earlier
analysis of k in normal individuals and nephrotic subjects
with membranous or minimal change nephropathy, we have
shown that extrapolation of the above-mentioned rat values
to the hydrodynamic model is unlikely to introduce major
errors [19]. The sensitivity analysis used in the present study
also suggests that variations in the Darcy permeability of
the “non-GBM” fibrinoid fraction of the glomerular capil-
lary wall are unlikely to introduce major errors in the
computation of k. We submit, therefore, that whereas the
actual values that we have computed for single nephron Kf
are likely to be of limited precision, the relative differences
in computed Kf values between the PET and control groups
of the present study are likely to be real.
A novel, but not surprising result of our analysis is that it
points to impairment of k as an important, and perhaps
predominant Kf-lowering phenomenon in this common
form of glomerular endothelial injury. Studies in the
healthy rat indicate that the GBM and the epithelial
filtration slit diaphragms each account for approximately
50% of resistance to water flow across the normal glomer-
ular capillary wall [25]. Because of its large and numerous
fenestrae the endothelial monolayer accounts for only 1 to
2% of transmural resistance [25]. A reduction in filtration
slit frequency, owing to broadening and effacement of foot
processes, is the major cause of impaired k in glomerular
injuries that are accompanied by nephrotic range protein-
uria [19]. Filtration slit frequency was essentially normal in
the present study, however. Instead, the density and size of
endothelial fenestrae was sufficiently reduced to permit the
endothelial layer to account for ;9% of resistance to water
flow. Even more important in curtailing water flow is the
fact that access to the basement membrane was limited by
the fenestral changes, such that the fraction of GBM
occupied by fenestrae was reduced below normal by 72%.
As a result, basement membrane resistance (1/kbm, equa-
tion 5) was increased along with endothelial resistance. The
presence in the subendothelial space of fibrinoid deposits,
along with modest thickening of the GBM, also served to
lengthen the extracellular pathway through which filtrate is
formed, and hence to further increase 1/kbm. Together the
aforementioned structural changes in and immediately
beneath the endothelial monolayer in PET appear to lower
k by ;30%, and to be largely responsible for the dimin-
ished Kf.
Whereas a Kf-lowering role for impaired k seems clear
cut, it is less obvious whether curtailment of S also serves to
lower Kf in PET. On the one hand, we have shown that
swollen endothelial cell bodies and interposed mesangial
cells impinge on the filtration barrier, thereby lowering
filtration surface density (Sv; Figs. 1 and 2). PET is also
complicated by a reversible form of focal and segmental
hyalinosis and glomerulosclerosis, a phenomenon that can
further compromise filtration surface density by obliterat-
ing segments of the capillary tuft in affected glomeruli [8,
37, 38]. On the other hand, we have shown that PET is
accompanied by glomerular hypertrophy, which serves to
offset the reduced filtration surface density, and results in a
nearly normal value for actual filtration surface area (Table
4). Worthy of emphasis, however, is that the control values
in Tables 3 and 4 are those of non-gravid female kidney
donors. Compared to the non-gravid state, pregnancy has
been reported to be associated with renal hypertrophy [39].
Should glomeruli share in this process of enlargement, the
offsetting effect of the disparity in glomerular volume
between PET and our present controls will be smaller or
disappear. Under these conditions, actual filtration surface
area in PET could be significantly depressed below gravid
control values, and contribute substantially to a low Kf in
PET. Of interest is the finding of heavy albuminuria despite
the absence of measurable deformation of podocytes. Con-
ceivably, impaired charge-selectivity, rather than filtration
diaphragm-related impairment of size-selectivity, is respon-
sible for albuminuria in this disorder. This was not assessed
in the current study.
We conclude that despite an absence of azotemia, the
GFR in PET is substantially depressed. Limitations of
available methods for evaluating the determinants of GFR
in the human kidney prevent us from determining defini-
tively whether reductions in filtration surface area or
filtration pressure contribute to the hypofiltration. How-
ever, impairment of hydraulic permeability of glomerular
capillary walls, a consequence of changes in and beneath
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the endothelial monolayer, is clearly implicated in, and is
likely to be the predominant cause of hypofiltration in PET.
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